Lv11
10 积分 2025-08-20 加入
Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised, active-controlled, phase 3a trial
5小时前
已完结
Screening Children for Early-Stage Type 1 Diabetes
6小时前
待确认
Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes
6小时前
已完结
Advanced delivery systems for oxygen therapeutics: center around red blood cells
6天前
已完结
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes
1个月前
已完结
Medical diagnosis based on artificial intelligence and decision support system in the management of health development
1个月前
已完结
Cardiorespiratory interactions during the transitional period in extremely preterm infants: a narrative review
1个月前
已完结
Expanding the Potential Treatment of Thyroid Eye Disease
2个月前
已完结
IGF-1R Inhibitor IBI311 for the Treatment of Active Thyroid Eye Disease in Chinese Patients
2个月前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
2个月前
已完结